Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
News|Webcasts|January 20, 2025
Advances in Small-Molecule Manufacturing
Webinar Date/Time: Fri, Feb 7, 2025 11:00 AM EST
Find out more about recent advances shaping small-molecule drug manufacturing, such as technological innovations and QbD principles that are enabling greater efficiency and improvements. Additionally, hear about potential emerging trends that may impact small-molecule manufacturing in the near future.
Register Free:
Event Overview:
In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, and Patrick Lavery, Editor, Pharmaceutical Technology Group, interview experts about advances in small-molecule manufacturing. During the discussion, various experts will detail recent advances that have enabled improvements in small-molecule manufacturing, such as technological innovations, quality-by-design principles, and complexity management. Additionally, sustainability initiatives and emerging trends will be touched upon.
Interviews featuring:
- Expert from Thermo Fisher Scientific
- A selection of speakers from CPHI interviews
Key Learning Objectives:
- Learning about recent advances shaping small-molecule drug manufacturing.
- Discovering technological innovations and QbD principles guiding more efficient small-molecule manufacturing.
- Highlighting emerging trends that will impact small-molecule manufacturing in the future.
Who Should Attend:
- Manufacturers
- Solid dosage drug manufacturers
- Quality personnel
- CDMOs
- Manufacturing operations personnel
- Engineers
Register Free:
Related to this article
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
USP data show fewer US drug shortages but longer ones, averaging 5+ years. Drug shortages are an incentive problem, not a manufacturing mystery.
Almac Clinical Services’ clinical supply strategy won the 2026 CPHI Award for Supply Chain Excellence. Nishma Patel, supply chain solutions manager, explains the benefits and challenges of the company’s just-in-time manufacturing solution.
Trending on Pharmaceutical Technology
1
Pimicotinib TGCT Approval Shows How Assessment Aid Supports Review
2
$1.15B AI-Guided Macrocycle Discovery Lands at argenx
3
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
4
Our Biggest Takeaways From AAPS PharmSci 360
5